Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-20 of 30
Keywords: von Willebrand factor
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Journal Articles
Regulation of ADAMTS13 Expression in Proliferating Human Umbilical Vein Endothelial Cells
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (2007) 36 (5): 233–240.
Published Online: 09 December 2009
...Stephen J. Kling; Cambria A. Judd; Keith B. Warner; George M. Rodgers ADAMTS13, the von Willebrand factor-cleaving protease, is constitutively produced by endothelial cells. The aim was to quantify ADAMTS13 production in proliferating and nonproliferating human umbilical vein endothelial cells...
Journal Articles
Highly Substituted Hydroxyethyl Starch (HES 200/0.62) Leads to Type-l von Willebrand Syndrome after Repeated Administration
Available to PurchaseJohannes Treib, Anton Haass, Gerhard Pindur, C. Miyachita, Markus T. Grauer, Friedel Jung, Ernst Wenzel, Klaus Schimrigk
Pathophysiology of Haemostasis and Thrombosis (1996) 26 (4): 210–213.
Published Online: 28 April 2009
... of highly substituted, high-molecular-weight starch often leads to iatrogenic von Willebrand syndrome (vWS) with hemorrhagic complications. In patients with cerebral circulatory disturbances we carried out hemodilution therapy during 9-10 days, infusing HES 200/0.62. A von Willebrand factor (vWF) multimeric...
Journal Articles
Femoral Artery Wall Morphology, Hemostatic Factors and Intermittent Claudication: Ultrasound Study in Men at High and Low Risk for Atherosclerotic Disease
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1996) 26 (1): 45–57.
Published Online: 28 April 2009
... with intermittent claudication. One hundred and thirty men at high cardiovascular risk and 51 men at low risk were examined. The subjects (high- and low-risk) with moderate/large plaque (n = 96) had higher fibrinogen, thrombin/antithrombin complex and von Willebrand factor, compared to subjects with small/no plaque...
Journal Articles
Haematology and Coagulation Indices in Paired Samples of Arterial and Venous Blood from Patients with Arterial Disease
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1996) 26 (2): 72–78.
Published Online: 28 April 2009
..., soluble P-selectin or von Willebrand factor. In venous samples, von Willebrand factor was lower in serum than in plasma (p < 0.0001). Levels of the tissue plasminogen activator/plasminogen activator inhibitor-1 (tPA/PAI-1) complex were markedly higher in arterial blood than in venous blood (p = 0.004...
Journal Articles
Electrophoretic Studies on Molecular Defects of von Willebrand Factor and Platelet Glycoprotein llb-llla with Antibodies Produced in Egg Yolk from Laying Hens
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1992) 22 (1): 32–40.
Published Online: 28 April 2009
... and immunoblotting conditions employed to explore human plasmatic and platelet von Willebrand factor (vWF) and human platelet GP Ilb-IHa using IgYs. These two proteins are involved in primary hemostasis and their absence or abnormality is responsible for hereditary bleeding disorders. The methods were applied...
Journal Articles
Biochemical Characteristics of Therapeutic Plasma Concentrates Used in the Treatment of von Willebrand Disease
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1994) 24 (5): 285–288.
Published Online: 28 April 2009
...Pier Mannuccio Mannucci Therapeutic plasma concentrates containing von Willebrand factor (vWF) lack the largest, most hemostatically active multimers. In order to evaluate whether this abnormality results from proteolysis during manufacturing, we have analyzed the subunit structure of vWF in 21...
Journal Articles
Biosynthesis of Human von Willebrand Factor
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1988) 18 (4-6): 224–245.
Published Online: 24 April 2009
... factor synthesized by endothelial cells is the von Willebrand factor (vWF). vWF is a large plasma glycoprotein which promotes the adhesion of platelets to the vessel wall after a vascular injury. vWF is initially synthesized as a pre-pro-polypeptide. During its transport to the outside of the cell...
Journal Articles
Storage and Secretion of von Willebrand Factor by Endothelial Cells
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1988) 18 (4-6): 246–261.
Published Online: 24 April 2009
...Jan Hendrik Reinders; Philip G. de Groot; Jan J. Sixma; Jan A. van Mourik Endothelial cells synthesize and store von Willebrand factor. We have studied the storage and secretion of von Willebrand factor in cultured human umbilical vein endothelial cells. In particular, we were interested...
Journal Articles
Further Evidence that the Residual vWf:Ag in Porcine FVIIL·C Induces Human Platelet Aggregation
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1990) 20 (5): 289–295.
Published Online: 24 April 2009
... a fall in single platelet count of up to 85% due to aggregation. The extent of aggregation was directly proportional to the amount (0.007–0.1 U/ml test aliquot) of residual von Willebrand factor antigen (vWl·Ag) in the preparations. A monoclonal antibody to vWl·Ag inhibited the aggregation. We believe...
Journal Articles
Enhanced Ristocetin-Induced von Willebrand Factor Binding to Platelet Glycoprotein lb in Patients with Steroid-Responsive Nephrotic Syndrome
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1990) 20 (4): 219–228.
Published Online: 24 April 2009
...Koji Taira; Hidekazu Kamitsuji; Chikako Okajima; Yoshihiro Fujimura To elucidate the mechanism of enhanced ristocetin-induced platelet aggregation (RIPA) in steroid-responsive nephrotic syndrome (SRNS), plasma levels of von Willebrand factor antigen (vWF:Ag) and ristocetin cofactor (RCof) were...
Journal Articles
Studies of von Willebrand Factor in Essential Thrombocythemia Patients Treated with Alpha-2b Recombinant Interferon
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1991) 21 (3): 135–140.
Published Online: 24 April 2009
...M.G. Mazzucconi; A. Ferrari; S. Solinas; A. Vitale; A. Chistolini; A.B. Federici; F. Mandelli The crucial role of the von Willebrand Factor (vWF) and its interaction with platelets in myeloproliferative disorders (MPD) have emerged in recent years. Recently, many authors have reported...
Journal Articles
Preparation of Factor-VIII-Depleted Plasma with Antibodies and Its Use for the Assay of Factor VIII
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1990) 20 (6): 321–328.
Published Online: 24 April 2009
... by another specific substrate for FVIII clotting assays. FVIII-deficient plasma was prepared by immunodepletion using polyclonal anti-von-Willebrand factor (vWF) and monoclonal anti-FVIII antibodies coated to agarose beads. This plasma, deficient in both FVIII and vWF, allows the evaluation of FVIII activity...
Journal Articles
Effectiveness, Specificity and Safety of Intranasal l-Deamino-8- D -Arginine Vasopressin Treatment of Normal Blood Donors
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1988) 18 (3): 187–196.
Published Online: 23 April 2009
... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. l-Deamino-8- D -arginine vasopressin VIIl:C von Willebrand factor Blood donors Haemostasis 18: 187-196 (1988) © 1988 S. Karger A G . Basel 0301 -0147/88/0183-0187S2.75/0...
Journal Articles
Modulation of Endothelial Cell Synthesis of von Willebrand Factor by Mononuclear Cell Products
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1988) 18 (3): 137–145.
Published Online: 23 April 2009
...Samuel N. Breit; Ira Green Von Willebrand factor (vWf:Ag) is an important product of endothelial cells whose major known functions are coagulation and platelet adhesion. It appears to behave as an acute-phase reactant, levels being elevated in the plasma in a wide variety of inflammatory disorders...
Journal Articles
Analysis of Platelet von Willebrand Factor Antigen
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1987) 17 (4): 217–225.
Published Online: 23 April 2009
...Kathy B. Thomas; Barry G. Firkin; Margaret A. Howard Platelet lysates were obtained from suspensions of normal washed platelets by freeze-thawing or Triton X-100 lysis. The resultant platelet lysates contained 0.34 ± 0.15 U/10 9 platelets (n = 8) of von Willebrand factor antigen (vWf:Ag...
Journal Articles
Von Willebrand Factor Fragment in Type IIA von Willebrand’s Disease: Demonstration of Two Different Forms of Fragments
Available to PurchaseHoyu Takahashi, Tsuneyasu Tsukada, Wataru Tatewaki, Masaharu Hanano, Masayoshi Sanada, Akira Shibata
Pathophysiology of Haemostasis and Thrombosis (1987) 17 (4): 182–188.
Published Online: 23 April 2009
...Hoyu Takahashi; Tsuneyasu Tsukada; Wataru Tatewaki; Masaharu Hanano; Masayoshi Sanada; Akira Shibata A fast-migrating precipitin peak which showed a reaction of partial immuno-chemical identity with the major von Willebrand factor (vWf) component was detected by crossed immunoelectrophoresis...
Journal Articles
Platelet Activation in Haemostasis: Role of Thrombin and Other Clotting Factors in Platelet-Collagen Interaction
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1977) 6 (1): 59–71.
Published Online: 16 April 2009
... for thrombin in collagen activation of platelets. Evidence was also obtained that von Willebrand factor may participate in this reaction. 16 4 2009 © 1977 S. Karger AG, Basel 1977 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated...
Journal Articles
Adhesion of Blood Platelets to Human Arterial Subendothelium: Role of Factor VIII-Von Willebrand Factor
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1979) 8 (3-5): 312–323.
Published Online: 16 April 2009
... with rabbit aorta previously, notwithstanding the essentially different nature of the human subendothelium, with its layers of smooth muscle cells above the internal elastic lamina. The system was used to study the role of factor VIII-von Willebrand factor (VIII-VWF). VIII-VWF was found to be the only plasma...
Journal Articles
Increase of a Plasma Factor Involved in Ristocetin-Induced Platelet Aggregation after Exercise
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (1974) 3 (3): 137–141.
Published Online: 15 April 2009
... to in the content or advertisements. Ristocetin Platelet aggregation Factor VIII Factor VIH-related antigen von Willebrand factor Hemophilia A Exercise Haemostasis 3: 137-141 (1974) Increase of a Plasma Factor Involved in RistocetinInduced Platelet Aggregation after Exercise J. Stibbe a n d P. M...
Journal Articles
Association between AMPD1 Gene Polymorphism and Coagulation Factors in Patients with Coronary Heart Disease
Available to Purchase
Pathophysiology of Haemostasis and Thrombosis (2006) 35 (6): 440–444.
Published Online: 06 January 2009
... metabolism, haemostatic variables and cardiac hypertrophy in patients (n = 109) with coronary heart disease. The plasminogen activator inhibitor-1 activity and the von Willebrand factor were higher in the CC homozygote group compared to the CT/TT group (p < 0.05). There were no differences between...
1